Kim McCleary
Showing 1–2 of 2 transcripts.
- Milken Institute56 min
Hacks on Health Care: How to Make a Vulnerable Industry Cyber-Secure
Kim McCleary, Joshua Corman, Kevin McDonald, Suzanne Schwartz, Mark Wilson, Josh Tenenbaum, Martha Minowski
Led by Kim McCleary, a panel of industry experts and regulators detailed how the convergence of legacy medical devices, severe talent shortages, and immense costs has created a "critical condition" for healthcare cybersecurity in the United States. Highlighting the Hollywood Presbyterian ransomware attack and a BlackBerry demonstration of infusing pump vulnerabilities, the discussion established that proof of potential harm is now sufficient for FDA intervention while exposing the market's $100-per-record data value and the impossibility of total technical prevention. To address these systemic risks, stakeholders were advised to integrate security into patient safety cultures, mandate transparency in device procurement, and leverage the NIST framework to shift focus toward risk containment and continuous response rather than unattainable prevention.
- Milken Institute1h 0m
Smart on Science: How Today's Patients Are Driving Cures
Kim McCleary, Bray Patrick Lake, Joe Selby, Mace Rothenberg, Lou DiGennaro, Tony Coles, Dr. Francis Collins
Five healthcare leaders, including representatives from Pfizer, PCORI, and the NIH, convened to discuss the paradigm shift from paternalistic care models to active patient partnerships in drug development. The panel highlighted how the Precision Medicine Initiative, corporate adaptations like Pfizer's early patient integration, and PCORI's methodology have accelerated trial designs and improved outcomes by prioritizing patient-defined endpoints. Moving forward, the industry aims to leverage real-world data and shared governance to reduce the $2.2 billion cost of development while ensuring research addresses the specific needs and lived experiences of patients.